National Health Investors, Inc. (NYSE:NHI - Get Free Report)'s share price reached a new 52-week high during trading on Tuesday after the company announced a dividend. The company traded as high as $66.10 and last traded at $65.15, with a volume of 113857 shares trading hands. The stock had previously closed at $64.25.
The newly announced dividend which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be given a $0.90 dividend. The ex-dividend date is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a yield of 5.48%. National Health Investors's dividend payout ratio is currently 115.02%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on NHI. Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a research note on Tuesday, January 30th. They issued a "buy" rating and a $69.00 price target for the company. Wedbush lifted their price target on National Health Investors from $64.00 to $66.00 and gave the company an "outperform" rating in a research note on Monday, March 18th. BMO Capital Markets raised National Health Investors from a "market perform" rating to an "outperform" rating and set a $67.00 price objective for the company in a research note on Tuesday, March 12th. Truist Financial lifted their target price on shares of National Health Investors from $55.00 to $58.00 and gave the stock a "hold" rating in a research report on Thursday, April 4th. Finally, StockNews.com lowered shares of National Health Investors from a "buy" rating to a "hold" rating in a report on Thursday, April 18th. Five research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $60.50.
Check Out Our Latest Research Report on National Health Investors
National Health Investors Trading Up 2.2 %
The company has a debt-to-equity ratio of 0.90, a current ratio of 10.27 and a quick ratio of 10.27. The firm's fifty day moving average is $60.81 and its 200-day moving average is $56.48. The firm has a market cap of $2.85 billion, a price-to-earnings ratio of 20.98 and a beta of 0.95.
Insider Transactions at National Health Investors
In other National Health Investors news, Director Charlotte A. Swafford purchased 10,000 shares of the company's stock in a transaction on Tuesday, February 27th. The shares were purchased at an average cost of $58.69 per share, with a total value of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares in the company, valued at $6,466,757.65. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 8.21% of the company's stock.
Institutional Investors Weigh In On National Health Investors
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of National Health Investors by 5.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,944 shares of the real estate investment trust's stock valued at $1,127,000 after buying an additional 1,190 shares during the period. International Assets Investment Management LLC increased its holdings in shares of National Health Investors by 3,690.7% during the fourth quarter. International Assets Investment Management LLC now owns 28,430 shares of the real estate investment trust's stock valued at $1,588,000 after acquiring an additional 27,680 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of National Health Investors by 4.6% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 189,221 shares of the real estate investment trust's stock worth $10,568,000 after purchasing an additional 8,316 shares during the period. Vanguard Group Inc. grew its position in National Health Investors by 0.4% in the 3rd quarter. Vanguard Group Inc. now owns 6,173,352 shares of the real estate investment trust's stock valued at $317,063,000 after purchasing an additional 22,443 shares during the period. Finally, Raymond James Financial Services Advisors Inc. increased its stake in National Health Investors by 14.4% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 30,971 shares of the real estate investment trust's stock valued at $1,730,000 after purchasing an additional 3,907 shares in the last quarter. 62.51% of the stock is owned by institutional investors.
About National Health Investors
(
Get Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
